挑战角膜疾病和microRNA表达:专注于罕见疾病和新的治疗前沿
Ludovico Alisi1, Francesca Giovannetti1, Marta Armentano1
1Department of Sense organs, Sapienza University of Rome, Viale del Policlinico 155, Rome 00166, Italy.
Survey of ophthalmology
|September 29, 2024
概括
微RNAs (miRNAs) 是角膜疾病的关键调节者,影响炎症和愈合等过程. 了解它们的作用可能会导致新的诊断工具和治疗具有挑战性的眼睛疾病.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 微RNAs (miRNAs) 是基因表达的转录后调节者.
- miRNAs 关键调节角膜细胞功能,包括增殖,分化,炎症和伤口愈合.
- 新出现的证据凸显了miRNAs在各种角膜疾病的发病过程中的重要作用.
研究的目的:
- 审查关于miRNAs在具有挑战性的角膜疾病发展中的作用的文献.
- 专注于特定的疾病:春季角膜结膜炎,神经营养性角膜炎,角膜炎,Fuchs内皮角膜缩症和四肢干细胞缺乏.
- 探索miRNA激动剂和抗剂的潜在眼科应用.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 在眼睛表面病理中分析miRNA表达特征.
- 针对miRNA的治疗策略的研究.
主要成果:
- miRNAs与各种角膜疾病的病理生理学有关.
- 在不同的眼睛表面病理中观察到不同的miRNA表达模式.
- miRNA激动剂和对抗剂显示出未来眼科治疗的潜力.
结论:
- miRNAs是角膜疾病发展和进展的关键调节者.
- 在生物流体中进行miRNA分析为非侵入性诊断工具提供了潜力.
- 了解miRNA的作用可以为眼睛表面疾病提供新的治疗策略.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K